Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL Meeting Abstract
| Authors: | Sehn, L. H.; Kamdar, M.; Herrera, A. F.; McMillan, A.; Flowers, C.; Kim, W. S.; Kim, T. M.; Özcan, M.; Demeter, J.; Hertzberg, M.; Trněný, M.; Salles, G. A.; Davies, A.; Hirata, J. H.; Cheng, J.; Ku, G.; Matasar, M. J. |
| Abstract Title: | Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 401s |
| Language: | English |
| ACCESSION: | WOS:000442916002577 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.7507 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7507 -- Source: Wos |
